Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

CR245

Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by CR245a
Unstained: $65.00 Add to Cart
H&E (CR245s*): $65.00 Add to Cart

Microarray Panel:Cervical squamous cell carcinoma tissue microarray with matched adjacent cervix tissue, containing 11 cases of cervix squamous cell carcinoma and 1 cervix adenocarcinoma, duplicate cores per case
Cores:24
Cases:12
Layout:6 cols × 4 rows
Core Diameter:2 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456 
A Ute Ute Ute Ute Ute Ute  
B Ute Ute Ute Ute Ute Ute  
C Ute Ute Ute Ute Ute Ute  
D Ute Ute Ute Ute Ute Ute Marked point
Legend: Ute - Uterine cervix

- Adjacent tissue 1.5 cm away from tumor, - Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage IIIb), - Malignant tumor (stage IIa), - Malignant tumor (stage IIb), - Malignant tumor (stage Ib)

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 58 Uterine cervix Squamous cell carcinoma 3 IIa T2aN0M0 Malignant
A2 2 F 58 Uterine cervix Cancer adjacent tissue (cervical canals tissue with adenomatosis) – – – Adjacent
A3 3 F 40 Uterine cervix Squamous cell carcinoma (chronic inflammation of cervical canals) – Ib T1bN0M0 Malignant
A4 4 F 40 Uterine cervix Cancer adjacent tissue (cervix tissue) – – – Adjacent
A5 5 F 28 Uterine cervix Squamous cell carcinoma 1 Ib T1bN0M0 Malignant
A6 6 F 28 Uterine cervix Cancer adjacent tissue (cervix tissue) – – – Adjacent
B1 7 F 53 Uterine cervix Squamous cell carcinoma 3 II T2N0M0 Malignant
B2 8 F 53 Uterine cervix Cancer adjacent tissue (chronic inflammation of cervical mucosa) – – – Adjacent
B3 9 F 55 Uterine cervix Squamous cell carcinoma 1 IIa T2aN0M0 Malignant
B4 10 F 55 Uterine cervix Cancer adjacent tissue (cervix tissue) – – – Adjacent
B5 11 F 39 Uterine cervix Squamous cell carcinoma 2 I T1N0M0 Malignant
B6 12 F 39 Uterine cervix Cancer adjacent tissue (cervix tissue) – – – Adjacent
C1 13 F 39 Uterine cervix Squamous cell carcinoma 3 IIb T2bN0M0 Malignant
C2 14 F 39 Uterine cervix Cancer adjacent tissue (chronic inflammation of cervical mucosa) – – – Adjacent
C3 15 F 40 Uterine cervix Squamous cell carcinoma 3 Ib T1bN0M0 Malignant
C4 16 F 40 Uterine cervix Cancer adjacent tissue (chronic inflammation of cervical mucosa) – – – Adjacent
C5 17 F 42 Uterine cervix Squamous cell carcinoma 3 IIa T2aN0M0 Malignant
C6 18 F 42 Uterine cervix Cancer adjacent tissue (cervix tissue) – – – Adjacent
D1 19 F 54 Uterine cervix Squamous cell carcinoma 3 I T1N0M0 Malignant
D2 20 F 54 Uterine cervix Cancer adjacent tissue (cervix tissue) – – – Adjacent
D3 21 F 45 Uterine cervix Squamous cell carcinoma 3 IIIb T1N1M0 Malignant
D4 22 F 45 Uterine cervix Cancer adjacent tissue (chronic inflammation of cervical mucosa) – – – Adjacent
D5 23 F 57 Uterine cervix Adenocarcinoma 1 IIIb T2N1M0 Malignant
D6 24 F 57 Uterine cervix Cancer adjacent tissue (chronic inflammation of cervical mucosa with moderate epithelial hyperplasia) – – – Adjacent
– – F 55 liver Hepatocellular liver cancer (tissue marker) 3 T3N0M0 Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2013 US Biomax Inc.   custsrv@biomax.us   Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal